AllianceBernstein’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
71,518
+43,818
+158% +$13.9M 0.01% 865
2026
Q1
$8.16M Buy
27,700
+2,630
+10% +$814K ﹤0.01% 1297
2025
Q4
$7.39M Buy
25,070
+7,010
+39% +$1.31M ﹤0.01% 1365
2025
Q3
$957K Buy
18,060
+20
+0.1% +$970 ﹤0.01% 2371
2025
Q2
$759K Sell
18,040
-33,076
-65% -$1.26M ﹤0.01% 2438
2025
Q1
$1.94M Sell
51,116
-27,511
-35% -$1.72M ﹤0.01% 1922
2024
Q4
$6.05M Buy
78,627
+60,587
+336% +$4.38M ﹤0.01% 1405
2024
Q3
$1.04M Hold
18,040
﹤0.01% 2307
2024
Q2
$746K Buy
+18,040
New +$853K ﹤0.01% 2450
2023
Q2
Sell
-5,380
Closed -$65.3K 3226
2023
Q1
$65.3K Hold
5,380
﹤0.01% 3070
2022
Q4
$192K Buy
5,380
+1,140
+27% +$35.6K ﹤0.01% 3018
2022
Q3
$144K Buy
4,240
+687
+19% +$34.2K ﹤0.01% 3082
2022
Q2
$131K Sell
3,553
-133,103
-97% -$14.2M ﹤0.01% 3095
2022
Q1
$20.9M Buy
136,656
+11,755
+9% +$2.41M 0.01% 907
2021
Q4
$36.9M Buy
124,901
+15,234
+14% +$4.47M 0.01% 718
2021
Q3
$30.4M Buy
109,667
+15,042
+16% +$4.08M 0.01% 783
2021
Q2
$25.9M Buy
94,625
+35,188
+59% +$12.6M 0.01% 833
2021
Q1
$29.2M Buy
59,437
+13,020
+28% +$9.26M 0.01% 795
2020
Q4
$38.3M Buy
+46,417
New +$27.1M 0.02% 659

Other funds holding PRAX

AllianceBernstein's PRAX Position: Q2 2026 in Review

AllianceBernstein increased its Praxis Precision Medicines (PRAX) stake by 158% in Q2 2026, buying an estimated $13.9M and bringing the position to 71,518 shares worth $23M. The position accounts for 0.01% of the portfolio, ranked #865.

AllianceBernstein first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. The position peaked at $38.3M in Q4 2020. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • AllianceBernstein held 71,518 shares of Praxis Precision Medicines worth $23M as of Q2 2026.
  • AllianceBernstein bought 43,818 Praxis Precision Medicines shares in Q2 2026, an estimated $13.9M.
  • Praxis Precision Medicines made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #865 holding.
  • AllianceBernstein first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
  • AllianceBernstein's Praxis Precision Medicines position peaked at $38.3M in Q4 2020.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.